Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Chronic Lymphocytic Leukemia (CLL)

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

Abstract

Employing a multicolour flow cytometry assay, 133 B-chronic lymphocytic leukaemia (B-CLL) cases were analysed for surface expression of CD38. Based on a cut-off value of 20%, CLL patients were categorised into a CD38-positive (20%, n = 56) and a CD38-negative subgroup (<20%, n = 77) and separately analysed for clinical and laboratory parameters. Patients in the CD38-positive cohort were characterised by an unfavourable clinical course with a more advanced disease stage, poor responsiveness to chemotherapy, short time to initiation of first treatment and shorter survival. In contrast, the CD38- negative group required minimal or no treatment, remained treatment-free for a longer time period and had prolonged survival (P < 0.05). CD38 expression was a robust marker in the majority of patients in that it was stable over time and not significantly influenced by chemotherapy. In conclusion, our data confirm recent studies suggesting a role of CD38 as a predictor of clinical outcome in patients with B-CLL.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS . Clinical staging of chronic lymphocytic leukemia Blood 1975 46: 219–234

    CAS  PubMed  Google Scholar 

  2. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F . A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer 1981 48: 198–206

    Article  CAS  PubMed  Google Scholar 

  3. Rai KR . Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment Haematologica 1999 84: 94–95

    PubMed  Google Scholar 

  4. Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA . Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia New Engl J Med 2000 343: 1750–1757

    Article  CAS  PubMed  Google Scholar 

  5. Zwiebel JA, Cheson BD . Chronic lymphocytic leukemia: staging and prognostic factors Semin Oncol 1998 25: 42–59

    CAS  PubMed  Google Scholar 

  6. Binet JL . Prognostic factors in chronic lymphocytic leukaemia Haematologica 1999 84: 96–97

    PubMed  Google Scholar 

  7. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 1999 94: 1840–1847

    CAS  PubMed  Google Scholar 

  8. Hamblin T, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 1999 94: 1848–1854

    CAS  PubMed  Google Scholar 

  9. Hamblin T, Orchard JA, Gardiner A, Oscier DG, Davis Z, Stevenson FK . Immunoglobulin V genes and CD38 expression in CLL Blood 2000 95: 2455–2457

    CAS  PubMed  Google Scholar 

  10. Thunberg U, Johnson A, Roos G, Thorn I, Tobin G, Sallstrom J, Sundstrom C, Rosenquist R . CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia Blood 2001 97: 1892–1894

    Article  CAS  PubMed  Google Scholar 

  11. Deaglio S, Mehta K, Malavasi F . Human CD38: a (r)evolutionary story of enzymes and receptors Leuk Res 2001 25: 1–12

    Article  CAS  PubMed  Google Scholar 

  12. Kumagai M, Coustan-Smith E, Murray DJ, Silvennoinen O, Murti KG, Evans WE, Malavasi F, Campana D . Ligation of CD38 suppresses human B lymphopoiesis J Exp Med 1995 181: 1101–1110

    Article  CAS  PubMed  Google Scholar 

  13. Deaglio S, Mallone R, Baj G, Arnulfo A, Surico N, Dianzani U, Mehta K, Malavasi F . CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes Chem Immunol 2000 75: 99–120

    Article  CAS  PubMed  Google Scholar 

  14. Höffkes HG, Schmidtke G, Uppenkamp M, Schmücker U . Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry Clin Diagn Lab Immunol 1996 3: 30–36

    PubMed  PubMed Central  Google Scholar 

  15. Bene MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F, Ludwig WD, Matutes E, Orfao A, Sperling C, van't Veer MB . The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL) Blood 1998 92: 596–599

    CAS  PubMed  Google Scholar 

  16. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia 1995 9: 1783–1786

    CAS  PubMed  Google Scholar 

  17. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Döhner K, Bentz M, Lichter P . Genomic aberrations and survival in chronic lymphocytic leukemia New Engl J Med 2001 343: 1910–1916

    Article  Google Scholar 

  18. Matrai Z, Lin K, Dennis M, Sherrington P, Zuzel M, Pettitt AR, Cawley JC . CD38 expression and Ig VH gene mutation in B cell chronic lymphocytic leukemia Blood 2001 97: 1902–1903

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work represents a part of MNs MD thesis. We are indebted to numerous colleagues for generously contributing information on the clinical course and treatment histories of the study patients.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dürig, J., Naschar, M., Schmücker, U. et al. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 16, 30–35 (2002). https://doi.org/10.1038/sj.leu.2402339

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402339

Keywords

This article is cited by

Search

Quick links